Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Carasent, Audiocast with teleconference, Q2'24

By Inderes7/12/2024, 6:00 AM
Carasent

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Donna
00:00 - 13:38

Good morning and welcome to our presentation on what's been quite a busy quarter with the takeover interest from EG, the releasing process and acquisition process in Germany. I'm really pleased with how we managed to keep it all together and deliver a solid quarter. And today, we will start with me giving some highlights and a company update. Then I will hand over to someone else to provide a financial update. Looking at the highlights for the second quarter, we signed two new contracts. The contract with Video Supply Metrics was already known at the last quarterly conference. So we spoke about that contract back then. And now, we've also signed the contract for the activities. And what's really important is that now, for all products except our smallest product, Aromas, we have secured strong growth going forward. WebRTC and HP already demonstrate strong growth, and we have secured contracts for all our other products, aiming to maintain robust growth going forward starting by late next year. At the same time, we implemented both strong and effective cost control measures, which should enable us to drive margins higher next year. So, this really has been a solid foundation going forward with this contract. Another highlight is that the process really continues. The first day of trading at Nasdaq Stockholm in Q4 will likely be in December. It looks like it will be a relatively easy process. As we all know, they are listed on a regulated market with similar requirements as the Nasdaq Stockholm. So it seems to be relatively easy. In the quarter, there were quite high one-time costs related to potential bids from entities such as EG. The releasing and acquisition projects in Germany will continue to have similar costs in the quarters going forward. But these are true one-time costs looking at growth. SAI not implemented. ARR is now up to $171.7 million. Okay. That's up from 2 million a year ago. So that we really translate into strong growth in the year from now. We see growth of 15% when it comes to recurring revenue. Uh, and that's the same as last quarter. Profitability-wise, we're close to cash breake it on that ability. And that includes all investments in Webdoc X, which, as you know, is a new solution for your market. So, we can manage to fund that ourselves from present business. And, if we compare to a year ago, our adjusted EBITDA is now up to 16% from 8%. And we're actually cash flow positive both in this quarter and last quarter. As mentioned, we keep doing well even though we're moving from consultancy income to recurring revenue. What's important to note is that we're transitioning from consultancy revenue to recurring revenue. It will not translate directly into better revenue because if we take away, say, one third of the consultancy income when implementing one of our systems for the customers, we cannot add that through, not to the annual error, but maybe we can add like a third of it. So in a couple of years' time, it will be much better than having this constant consultancy revenue as we have so little churn. So it will readjust stronger over time. Revenues over time will hurt us a little bit short-term, but are still growing. And what's worth mentioning, I would say, is that you see that we sold the controller. So that takes down revenues a bit for this quarter compared to last quarter and previous quarters. EBITda is up to -2%, as mentioned, and EBITDA, which along with growth, is the most important KPI for us internally. So we're getting really close to being regular, not on that level yet, and then we'll continue to improve from there. Delving a bit deeper into revenues, we can see that we grew by 3 million compared to the same quarter last year. If we take away concrete figures, we grew by 5 million compared to the same quarter last year. And then, if you also add some not yet implemented quarterly recurring revenue, we grew by 9 million. So from half a million a year ago to 4 million. A little bit more on a formula basis this quarter. So in total, I would say that our growth rate has increased to 9 million NOK. You can also see that recurring revenue is becoming a larger part of our total revenues. So it's 61 million in this quarter compared to 54 million, the same quarter last year. It's not that we do not have any consultancy revenues at all. We do some work which should generate consultancy revenues and also cater to different customers, especially with the ones that have signed a lot of contracts and have different, um, needs or requirements. When it comes to what is easier for them, either paying recurring revenue or consultancy revenue. So some customers really prefer the long-term cost benefits of implementation. And it also really reflects on the short-term side of revenues. Looking at EBITDA, we improved from -11 to -1 million NOK. Or if we exclude Webdoc X, uh, we're moving from -4 million to an improvement of 4 million in this quarter. Delving a bit deeper into financial performance. As previously mentioned, we have a well-functioning base. And that's all products, except for HPI and Ad Opus, and their operations. They account for 87% of our revenues and have an organic return growth rate of 16%. And what's worth mentioning then, is that the metric has actually strengthened in the quarter, shrinking by 15%. Is that, um, the new deal with Walmart? We are doing a lot of consultancy work for them. And uh, during the coming 12 months, this work, which we priced very low, will see a much stronger recovery usage where the internet did. So it really hurts us here now. But a year from now, when we're implementing, uh, to get all of us, we will have new recurring revenue of 6 million from them. And then all the consulting work will also be at full price again. So a year from now, that would really help us drive growth and profitability. But that's a short, short term. Uh, for operations, the money is now. EBITDA margin has now increased to 25% from 20% a year ago, and cash profitability is up to 17% from 12% a year ago. If we look at each of the two products, we will face some more challenges. We are making large improvements there as well. Uh, that segment, which represents only 12% of our revenues, had organic growth of 7% in the quarter. And then we should mention that HP's growth was actually 25% in the quarter. So, HP is performing really well now. I know this is still not glowing, but we have Adobe Web upcoming, which we really believe in. And now, with the first customers coming online, they will help us spread the word. So I'm very positive about this product too. Um, those two are now at 2 million, and the losses kept close to zero. For those two products, we have managed to lower costs a bit more. Uh, we're now at -6 million from -7 million in capex. Uh, and we continue to transition that group from consultants to employees. Um, and during June, we've removed the last consultants in that group, and starting after summer, we will only have employees. So this will help us control costs in the next quarters, and in the coming quarters at the head office, we've gone from -8 million up to -5 million. Okay. Uh, and I think that's a reasonable level and roughly where we will be going forward. So, looking ahead, we will continue to develop our sales model. Uh, as I mentioned before, we are really doing a lot with our marketing and sales, focusing on inbound marketing and our own sales activities. Um, we have revamped all our webpages. We have done a lot of advertising on LinkedIn and other social media, applying search words and so on. And, we are still learning. I would say, it will take some time for us to really move into a different mode of selling. But I really believe in that. Many of our potential customers know they need to change systems, but it's quite a big change for a business, or for a clinic or hospital. And we need to help them make the decision and push them over that hurdle. Given how satisfied the customers who have migrated to our systems are, both with the systems and with the process, we can really market that. But, something that will take us some time to learn and get better at. Another focus for us in order to deliver this strong organic growth is to ensure timely delivery of new development. Basically, all of our products are dependent on us delivering our solutions on time, for those customers. So that's an important area for us to focus on. Efficient use of resources is something that we work on every day, and we continue to improve continually. So every quarter gets 3 or 4% more efficient, And over time, this translates into significant improvements. The most important part of running the business is to always improve much quicker than new problems arise. That's really where each one of us focuses our attention. When it comes to Webdoc X, it now looks most likely that we will certify it in Q1 next year. And then we'll have a system which is ready to be used in Germany. There will still be, a lot of, small parts of different types of categories we need from the systems, but then we will be able to start rolling it out to the first customers. It's been a very intense quarter when it comes to our operations in Germany. We have had many discussions with possible pilots, acquisition targets, and also collaboration partners. We spent a lot of time in Germany this quarter, and every time we are there talking to customers, talking to potential partners, we feel stronger and more convinced that this is the right place for us to be. So I really look forward to starting to roll it out during next year. With those words, I will hand over to someone. Thank you, Donna. Some of the highlights here. From a financial perspective, this quarter was a clear step in the right direction. Firstly, we showed that our underlying

Unknown 1
13:38 - 13:39

revenue

Donna
13:39 - 13:39

growth

Unknown 1
13:39 - 13:39

is

Donna
13:39 - 13:41

robust.

Unknown 1
13:41 - 21:02

With 15% recurring revenue growth. Additionally, our signing of new contracts indicates promising growth for the next period. Secondly, our margins are improving, with a margin increase to 16% and EBITDA margins, with capex close to zero. Our signed ARR grew 20% organically, year over year. This growth was driven by a major increase in our backlog and implemented ARR. Due to the large contracts we have signed, we did not have these types of contracts in the previous few years. The last contract of this magnitude was aimed at bolstering our security in 2021. And now, we have signed three such contracts within the last couple of quarters. This is clearly setting a very solid foundation for accelerated growth in the coming years. Even without these contracts, we still achieved very solid growth this quarter, with a net upsell of 13%. Churn continues to be very low, presenting a year-over-year decrease. We also continue to see an influx of new customers, mainly for Webdoc X, where we continuously sign new clients. It was 4% in the quarter. This is a very important part of our growth strategy, as these customers typically start with a lower price and then add more functionality, paying more and growing their business faster than the market, which is a typical profile of our regular customers. Looking at the P&L for the group, there are some points worth highlighting as well. Firstly, we have good underlying growth across all product categories. If we look at the year-over-year figures, there's an increase of 17% or 18%, adjusted for currency, which is strong, and around 20% for the first half of this year. The other category grew 9%, adjusted for currency. For this category, we have signed significant contracts, including one for a partnership with EG. The parentheses indicate a decrease, totaling around 10 million ARR. When you compare this to the figures we are now reporting, it's evident that we have secured very strong growth. Only from these contracts alone, this category is projected to grow significantly in the next few years. The platform products, as you can see, declined due to the divestment of Frelsesarmeen. However, adjusted for currency, it grew nicely at 14%. This is the HPI metric. And here we also have a bigger contract of 6 million a year starting next year. Moreover, SBI's strong underlying growth makes this category well positioned for the coming period. Additionally, as mentioned by Daniel Öhman, consulting the client has proven beneficial. The gross profit margin increased from 82% to 85%. This increase was because we sold comfrey, which had a dilutive impact, but also because we renegotiated with our hosting supplier in Norway. Uh, reducing costs quite significantly. So, you can see that even though revenues increased by 3 million. COGS actually decreased by 1.3 million. This is a very nice improvement for us. Um, and, if you look at the profitability as well, you see major increases in EBITDA and we are close to breakeven on EBITDA capex. And if we exclude the investments into Germany, where we now have an EBITDA of 4.4 million in the quarter or a 7% margin, it's improving rapidly. We constantly work on the cost base. In this quarter, we have engaged R&D consultants with an impact of six to seven million on an annual basis. Some of these will be replaced by employees, but the net impact is positive for us. We are also in the process of migrating to a new hosting solution in Sweden that will reduce costs. Additionally, when we transition customers from other platforms to our services, we can significantly reduce the cost of goods sold (COGS) for that product, which remains relatively high. Um, so these are some examples. In general, our plan is to keep costs flat and grow revenues. And to achieve that, we need to make these cuts and become more efficient. Um, because we need to add costs in other places, such as sales and compliance, etc.. But we see the potential to continue to become more efficient as we grow. We have a higher gross margin, so if we are able to keep costs flat, then we can scale our margins quite rapidly, as you can see from this slide. Finally, we have positive cash flow in Q2, driven by improvements in profitability, a good working capital effect from annual invoicing for some of our products, and a dramatic reduction in capex. In summary, from a financial perspective, we continue to grow well. Our underlying growth is robust. We have signed major contracts for future growth, and our profitability is improving rapidly. So with that, we can open up for Q&A.

Operator
21:08 - 21:22

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please press the pound key six on your telephone keypad.

Unknown 1
21:30 - 21:40

We don't have any questions from the call-in line, but we have several questions posted in the chat.

Donna
21:40 - 21:41

So we can.

Unknown 1
21:41 - 21:59

Start with the first one from Amelia to me. Uh, any updates on your targets of organic growth and profitability? Are you confident you will reach the target of 15% organic growth? Do you also expect to break even on EBITDA for the full year?

Donna
22:00 - 22:12

Yes, thank you for that question. Um, yes, I would say that our targets are solid. Um, and we're delivering on those. So, we're pleased with where we are and

Unknown 1
22:12 - 22:12

are moving

Donna
22:12 - 22:29

forward in a good fashion. This type of business is quite straightforward compared to others, especially in a small town setting. We know the rate of our growth and we can maintain good cost control.

Unknown 2
22:31 - 22:31

Yes.

Unknown 1
22:33 - 22:49

Next question from the market. Ready? First, could you comment on the quarter over quarter growth rate in Webdoc X? Was there some churn, currency impact, or just lower activity among clinics?

Donna
22:50 - 24:08

Yes. So, there will always be some ups and downs. When it comes to growth, we've either signed a large clinic or a couple of smaller ones, or not. So we're growing roughly around 20% in the first half of the year. What we did have in the quarter, which impacted this quarter a bit, was that we had a couple of customers who came online stating their volumes were much lower than expected. In Webdoc X, we charge per visit. In the regular pricing increases we implement, we look at the number of visits our customers have had in the last period, and then adjust by the growth data. When there's a new customer, we charge them based on the projected number of visits they say they will have or have had, and especially one large customer was not even close to their projection. I think there was some miscommunication. It was more what they intended for their growth going forward, not really what they had achieved. So, we had to issue some refunds in this second quarter. However, we're doing well. And we continue to grow at roughly 20%.

Unknown 1
24:09 - 24:22

Yes, there were some currency effects also compared to the last quarter, but then the growth rates of around 20% for each one is representative of where we are currently heading.

Unknown 2
24:24 - 24:24

Um.

Unknown 1
24:25 - 24:31

Next, how does a new clinic sign up for Webdoc X?

Donna
24:33 - 25:16

So, yes, we actually had the first couple of so-called cold calls where it's us reaching out to customers, not them reaching out to us. We've managed to close contracts, so I'm really happy about it. It's still as we spoke about, and at the time, it has been for quite some time a challenging market for selling, especially with Ad Curis, where there are many unknowns in making these types of big decisions, such as changing systems. You don't do that when you have a lot of unknowns around you. So, it's a bit of a challenging market. It's been there for quite some time.

Unknown 2
25:16 - 25:17

And, uh.

Donna
25:17 - 25:27

And it will be sold for quite some time going forward. But still, we managed to grow at around 20%, so I'm quite happy about it. Um, yeah.

Unknown 1
25:29 - 25:40

Great.

Donna
25:40 - 27:53

Yeah. So, in Stockholm, we have. The new leaders in Stockholm have been really trying to move care from private providers to public providers. I'm very doubtful that that will actually happen. So it will probably result in less care in total and more tubes in Stockholm. And then there would be more private care again. So long term, the trend has been for a very, very long time that the private care as part of the total care is increasing. That's because the private care providers are obviously much more efficient. Um, and I think that's what will happen later on, but shorter. She has noted a movement away from private care provided by private providers to public-private partnerships. But for us, it's not really a major problem, because what's happening in Stockholm is that many of these private clinics are transitioning from public to private care, and private care includes both insurance and private payments due to the pressing need for care. If the public provides less care to the population, more law enforcement will become necessary, which will pay for itself. I have insurance authority, and Webdoc X is really effective when you have a mix of different buyers of care. So, Docker actually supports us and many of our customers. They use Webdoc X for private insurance patients and they use Take Care for the public patients. So they use two systems in one clinic. That's what we want to move away from with the new referral solution and so on. Moving away from that has been the case. And also, our stock market is quite small. So even if the market is not growing at the moment, we can still grow. So, I don't think and we don't see any major impact on us. And it can be both a bit positive and negative.

Unknown 1
27:55 - 29:10

All right. Next one. How much further can you strengthen your gross margin roughly? I would say the most near-term improvement we have there is moving lupus customers to the web. Although this is the case, we have costs there which are around 1% or a bit more of our revenues today. So that could be an improvement. But it will take some time to materialize. The web hosting cost, this is reported in our financial statements, and it's not directly linked to the sales. So there will also have potential, but that won't improve the gross margin in the short term. We have also quite high costs for our older product in Norway, but that's more a long-term potential. And next one, you say that you deliver new development on time. Can you talk a bit more about the development and launch of this web? The surgical functionality and web document updates. Yeah.

Donna
29:10 - 33:09

So I think what I said was that it's important to deliver new developments on time. And anyone who is familiar with software knows that that's part of the challenge of working with software. It's very important to have a really efficient development tool, with clear processes and talented employees who enjoy their work. And that's what we work a lot with. And so Adobe's Web was developed far before it started being developed before I joined. I don't know what the timeline was back then. But it's a really good product from what I can see. It's a really good product, but it's always the customer who decides when it meets customers' needs. But the first customers are really happy about it. And now we will move our largest customer from the other platform to this web. So it will be really interesting to see how that plays out. And then it's word of mouth, which is really important. We are also working with marketing to strengthen the message. But if all industries are quite small, so you typically talk to someone else and ask, 'How is that working?' But we believe that this is where we really change the view of advocacy among consumers. Margie was asked about the webcam. Okay, so the title function on Webdoc X will roll out, uh, for first pilots in summer, a month or two after the vacation and, uh, be ready to be sold, uh, in October and November and rolled out in a general fashion around, uh, next year. So then that's when everyone can use it. Uh, it's taken a bit more than the 12 months we planned for. Uh, so first we had. So the development time is maybe 14 to 15 months from the 12 months, which we had planned for. Uh, but we're getting better, and we need to keep getting better at, um, the pace of development. Uh, and that also goes for the case where we've made a lot of improvements in how we develop the team composition, the management, uh, basically all management of where X has been replaced in the last 12 months. Uh, and I've said that we have a really good pace there now and tend to like what they do and really enjoy the energy of building a new system. So I'm confident about the gates being a really good system. And then it takes time to really meet all the needs of the customers. These are big, complex systems. Now, what's important is to work closely with customers to make sure that we build things that the customer really appreciates and ensures that we do not overcomplicate things by building things just for the sake of building. We need to build what the customers actually need. Financial markets risk having a competitor, like conducting a due diligence on you. Um, I'm not really. Uh, so we knew that EG was a competitor. So the diligence was, uh, sensitive information that we did not want to give a competitor we cannot give to you. And that's always how you have to choose to do it. So if you have someone who wants to put a bid on you, then obviously you, uh, give them access to as much as possible for them to be able to give their bid. But then you have to restrict access to things that a competitor might take advantage of. And I think we found a good balance in this.

Unknown 1
33:12 - 33:18

Uh, next one is from Christopher Goff. And what are the overall.

Donna
33:18 - 33:19

Expectations.

Unknown 1
33:19 - 33:31

Both for the company and existing shareholders with the move to the Nasdaq Stockholm Exchange and the capital markets, the plan related to the move.

Donna
33:32 - 34:21

So we see that, I mean, most of our employees are in Sweden. Most of our customers are in Sweden. The interest for companies like ours is in Sweden and in Norway. So we believe that the Nasdaq Stockholm is the right exchange for us. Um, yes. We're looking to make it as easy for all shareholders to transfer the shares and to keep holding the shares in Carasent. Um, we are planning for travel plans for capital market days. Yes, it is, but we're planning for, uh, activities to make us more well known to the public in Sweden so that we look forward to doing this during the autumn. Um, yeah.

Unknown 1
34:23 - 34:29

Uh, okay. Final question from Alexander. Uh, it's in Swedish, but I will try.

Donna
34:29 - 34:31

To try to translate. Um.

Unknown 1
34:32 - 34:47

During the quarter, we have experienced a strike within the healthcare sector in Sweden. Uh, the parties agreed, but the union leaders flagged that more such incidents could occur going forward. How does this impact our personnel?

Donna
34:48 - 36:18

So, um, our customers were not directly affected in a major way. So it's nothing that we see in our revenues. and are unlikely to see. What it means is that wait times, which are already long, will keep getting longer. Ever since the pandemic, the system has lost even more of the efficiency tools introduced during that time. Uh, and now with this trade strike, delays are growing even more. So, it will obviously put a lot of pressure on the system. And that's really where we can support them. Uh, our products help our customers become more efficient and able to care for more patients per hour. Uh, so, um, we believe that it's not something that is most likely to have a positive effect on us. Uh, especially in the long term, as when the kids grow up, either the public will have to buy more services from private providers or more patients will be visiting. They cannot be sold insurance; that kind of thing. So, and that's where Webdoc X comes in, but also many of our other products. So we don't see it having any negative impact on us, plus possibly a positive effect.

Unknown 1
36:21 - 36:23

Okay. That was the final question.

Donna
36:23 - 36:30

Okay. Then I would like to thank you all for your interest today and wish you all a really good summer. Thank you for now. Thank you.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…